Shingo Kitagawa
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Liquid biopsy in lung cancer.
Journal: Japanese journal of clinical oncology
Published: September 16, 2024
IgA vasculitis induced by carboplatin + nab-paclitaxel + pembrolizumab in a patient with advanced lung squamous cell carcinoma: a case report.
Journal: Frontiers in immunology
Published: January 15, 2024
Prognostic value of predominant subtype in pathological stage II-III lung adenocarcinoma with epidermal growth factor receptor mutation.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: October 25, 2023
First-line osimertinib in EGFR mutation-positive non-small cell lung cancer patients with poor performance status.
Journal: Future oncology (London, England)
Published: November 11, 2021
Durvalumab-Induced Secondary Pure Red Cell Aplasia Successfully Treated With Cyclosporin.
Journal: JTO clinical and research reports
Published: April 19, 2020
Efficacy of immune checkpoint inhibitor monotherapy for patients with massive non-small-cell lung cancer.
Journal: Journal of cancer research and clinical oncology
Published: March 13, 2020
Pembrolizumab and salvage chemotherapy in EGFR T790M-positive non-small-cell lung cancer with high PD-L1 expression.
Journal: OncoTargets and therapy
Published: September 22, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026